Sophiris' p2 trial due Around june is bound to succeed being they directly inject their cell killing protein into tumors in low risk prostate cancer..........should be an interesting JUNE
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.